1. Sanofi, despite the pandemic, sees early gains from CEO Hudson's strategy — Trump administration to require insurers to cover COVID-19 vaccine — Regeneron/Sanofi's Libtayo gets priority review in NSCLC — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Edit Tags: Merrimack sure is going places.

Multiple tags may be separated by commas.